Labcorp (NYSE: LH) SVP logs RSU vesting and share withholding

Rhea-AI Filing Summary

Labcorp Holdings Inc. executive Peter J. Wilkinson, SVP and Chief Accounting Officer, reported multiple equity award transactions. On February 6 and 7, 2026, Restricted Stock Units (RSUs) vested and were converted into 133 and 134 shares of common stock, respectively, each RSU representing one share.

To cover tax withholding obligations related to these vestings, 45 shares at $277.20 per share on February 6 and 46 shares at $274.01 per share on February 9 were withheld. After these transactions, Wilkinson directly held 2,028.2194 shares of Labcorp common stock and 2,224 RSUs in total.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wilkinson Peter J

(Last) (First) (Middle)

231 MAPLE AVENUE

(Street)

BURLINGTON NC 27215

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/06/2026		M		133	A	(1)	1,985.2194	D
Common Stock	02/06/2026		F(2)		45	D	$277.2	1,940.2194	D
Common Stock	02/07/2026		M		134	A	(1)	2,074.2194	D
Common Stock	02/09/2026		F(2)		46	D	$274.01	2,028.2194	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	02/06/2026		M			133	(3)	(3)	Common Stock	133	$0	2,358(4)	D
Restricted Stock Unit	(1)	02/07/2026		M			134	(5)	(5)	Common Stock	134	$0	2,224(4)	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

5. The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Peter J. Wilkinson	02/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did Labcorp (LH) report for Peter J. Wilkinson?

Labcorp reported that SVP and Chief Accounting Officer Peter J. Wilkinson had RSUs vest into 133 and 134 common shares, with related share withholding for taxes. Following these transactions, he directly held 2,028.2194 common shares and 2,224 Restricted Stock Units.

How many Labcorp RSUs vested for the SVP, Chief Accounting Officer?

A total of 267 Labcorp RSUs vested for the SVP, Chief Accounting Officer, split into 133 units on February 6, 2026 and 134 units on February 7, 2026. Each unit converts into one share of Labcorp common stock upon vesting.

Why were Labcorp (LH) shares withheld in this Form 4 filing?

The filing states that certain Labcorp shares were withheld to satisfy tax withholding obligations triggered by RSU vesting. Specifically, 45 shares at $277.20 and 46 shares at $274.01 were withheld instead of cash, a common method for covering associated tax liabilities.

How many Labcorp common shares does the reporting person hold after these transactions?

After the reported transactions, the SVP, Chief Accounting Officer directly holds 2,028.2194 Labcorp common shares. This figure reflects RSU conversions into stock and subsequent share withholding for taxes, as detailed in the non-derivative transaction table.

How many Restricted Stock Units does the Labcorp executive hold after the Form 4 events?

Following the vesting events, the executive holds 2,224 Labcorp Restricted Stock Units in total. The footnotes explain this number represents the aggregate RSUs still held, separate from common shares already issued upon prior vesting.

What do Labcorp Restricted Stock Units represent in this Form 4?

Each Labcorp Restricted Stock Unit in the filing represents a contingent right to receive one share of Labcorp common stock. The units vest in three equal annual installments under the described grants, after which they convert into common shares at no exercise price.